How to diagnose rhabdomyosarcoma in children?

Update Date: Source: Network

summary

Rhabdomyosarcoma is a kind of malignant tumor of rhabdomyosarcoma or mesenchymal cells differentiated into rhabdomyosarcoma, which mostly occurs in children's head and neck, orbit and genitourinary organs. So some patients have proposed how to diagnose rhabdomyosarcoma in children?, Today I'd like to share this with you.

How to diagnose rhabdomyosarcoma in children?

The first: rhabdomyosarcoma obvious symptoms in children's head and neck, eye and other organs grow tumor, other symptoms include nasal congestion, nosebleed, headache, poor sense of smell, poor breathing, remind parents not to go wrong, the above symptoms are not only children with a cold and fever will have!

Second: Generally speaking, the most conventional treatment in China is to remove the cancerous part. However, because the children are still young, and there is still a long way to go, hospitals will not recommend surgical resection for children, and striving for limb preservation has become a widely adopted treatment method in most hospitals in China. It should be noted that the early stage of rhabdomyosarcoma can lead to lymph node metastasis, so some patients need to undergo lymph node dissection in the drainage area at the same time of chemotherapy. However, according to the current domestic treatment data, the 5-year survival rate of rhabdomyosarcoma is less than 25%.

Third: is there really no better way to treat rhabdomyosarcoma? At present, proton therapy is the most authoritative treatment for rhabdomyosarcoma in the world. Proton therapy for rhabdomyosarcoma is the most advanced instrument for the treatment of children's tumors. It can effectively kill cancer cells in the body of patients without worrying about other injuries to the child's body.

matters needing attention

In the risk classification of neuroblastoma in China, age is one of the factors, but the more important factors are metastasis at the onset of the tumor, the range of invasion and whether there are high-risk genes, such as N-myc gene detection.